DOCSLIB.ORG

Substance Use in Pregnancy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Substance Use in Pregnancy MAY 2017 SUBSTANCE USE IN PREGNANCY Prepared By: Aaron Fields, MD University of Rochester Medical Center, NYS Maternal & Infant Health Center of Excellence 265 Crittenden Blvd, Rochester, NY 14642 – Tel: 585-276-7893 – Fax: 585-461-4532 [email protected] – www.mihcoe.org Introduction ..............................................................................................................................................................2 What is Addiction? .....................................................................................................................................................3 Drugs of Abuse ..........................................................................................................................................................4 Opioids ................................................................................................................................................................................ 4 Stimulants ........................................................................................................................................................................... 4 Nicotine............................................................................................................................................................................... 5 Alcohol ................................................................................................................................................................................ 6 Marijuana ............................................................................................................................................................................ 8 Sedative-Hypnotics ............................................................................................................................................................. 9 Hallucinogens.................................................................................................................................................................... 10 Inhalants ........................................................................................................................................................................... 10 Rates of Drug Use .................................................................................................................................................... 11 Opioids .............................................................................................................................................................................. 11 Stimulants ......................................................................................................................................................................... 12 Nicotine............................................................................................................................................................................. 12 Alcohol .............................................................................................................................................................................. 13 Marijuana .......................................................................................................................................................................... 13 Sedative/Hypnotics ........................................................................................................................................................... 14 Hallucinogens.................................................................................................................................................................... 14 Inhalants ........................................................................................................................................................................... 15 Effects of Drug Use During Pregnancy ....................................................................................................................... 16 Opioids .............................................................................................................................................................................. 16 Stimulants ......................................................................................................................................................................... 16 Nicotine............................................................................................................................................................................. 17 Alcohol .............................................................................................................................................................................. 17 Marijuana .......................................................................................................................................................................... 17 Sedative/Hypnotics ........................................................................................................................................................... 17 Hallucinogens.................................................................................................................................................................... 18 Inhalants ........................................................................................................................................................................... 18 SBIRT for Drug Use ................................................................................................................................................... 19 What is SBIRT? .................................................................................................................................................................. 19 Screening Tools ................................................................................................................................................................. 19 Signs and Symptoms of Addiction .................................................................................................................................... 20 Brief Interventions ............................................................................................................................................................ 21 Referral to Treatment ....................................................................................................................................................... 24 Mandatory Reporters ....................................................................................................................................................... 25 References ............................................................................................................................................................... 26 Appendix A: National Organizations Definitions of Addiction .................................................................................... 31 American Society of Addiction Medicine (ASAM) ............................................................................................................ 31 The National Institute on Drug Abuse (NIDA) .................................................................................................................. 31 Appendix B: Screening Tools .................................................................................................................................... 32 AUDIT-C ............................................................................................................................................................................ 32 NIDA Quick Screen ........................................................................................................................................................... 33 CRAFFT ............................................................................................................................................................................. 40 Introduction Although the opioid epidemic has become a popular topic of conversation in political and public policy arenas, many in the healthcare system have known for years that there was an impending tidal wave of people dependent on opioids and other drugs, which were preventing them from fully engaging as contributing members of society. The fields of Addiction Medicine and Addiction Psychiatry have been present in one form or another in the United States since the latter half of the 18th century. It wasn’t until the 1950s and 1960s that physicians specializing in addiction began to organize. Thanks to the efforts of those pioneers of addiction treatment during the 1950s and 1960s, by the 1980s, the wider medical establishment was beginning to acknowledge the importance of specialized addiction treatment.1 The purpose of this report is to summarize the current body of information and evidence regarding drug addiction during pregnancy. This report begins with a description of what addiction is and how it occurs. This is followed by a synopsis of what many of the more commonly abused categories of drugs are, and some basics about how these drugs cause their effects. Next, an overview of the rates at which the different categories of drugs are abused in the United States and among pregnant women (when such data is available), and the effects these drugs have on a developing fetus/infant and on the mother. Finally, the report concludes with an introduction
Load more

Recommended publications
  • Download/Rozdzial05.Pdf (Accessed on 1 January 2007)
    cancers Article Early Alcohol Use Initiation, Obesity, Not Breastfeeding, and Residence in a Rural Area as Risk Factors for Breast Cancer: A Case-Control Study Dorota Anna Dydjow-Bendek * and Paweł Zagozd˙ zon˙ Department of Hygiene and Epidemiology, Medical University of Gdansk, 80-211 Gdansk, Poland; [email protected] * Correspondence: [email protected] Simple Summary: Breast cancer became the most common cancer globally in 2021, according to the World Health Organization. The aim of the study was to evaluate risk factors for breast cancer, such as early alcohol use initiation, obesity, breastfeeding, and place of residence. The effect of alcohol consumption by girls has been assessed in only a few studies and is not fully understood. In this study, it has been found to be associated with a higher risk of breast cancer. Our study also shed light on the incidence disparity—women were more at risk in the countryside than in the city. The results of this study should be included in the preparation of breast cancer prevention programs and also aimed at women in adolescence and early adulthood because exposures during childhood and adolescence can affect a woman’s long-term risk of breast cancer. Every effort should also be made to ensure that access to knowledge is open to all, regardless of where they live, giving all women equal opportunities. Citation: Dydjow-Bendek, D.A.; Zagozd˙ zon,˙ P. Early Alcohol Use Abstract: Initiation, Obesity, Not Breastfeeding, The aim of this study was to determine the risk factors for breast cancer in the Polish and Residence in a Rural Area as Risk population.
    [Show full text]
  • Anatomy of the Human Mammary Gland: Current Status of Knowledge
    Clinical Anatomy 00:000–000 (2012) REVIEW Anatomy of the Human Mammary Gland: Current Status of Knowledge 1,2 1 FOTEINI HASSIOTOU AND DONNA GEDDES * 1Hartmann Human Lactation Research Group, School of Chemistry and Biochemistry, Faculty of Science, The University of Western Australia, Crawley, Western Australia, Australia 2School of Anatomy, Physiology and Human Biology, Faculty of Science, The University of Western Australia, Crawley, Western Australia, Australia Mammary glands are unique to mammals, with the specific function of synthe- sizing, secreting, and delivering milk to the newborn. Given this function, it is only during a pregnancy/lactation cycle that the gland reaches a mature devel- opmental state via hormonal influences at the cellular level that effect drastic modifications in the micro- and macro-anatomy of the gland, resulting in remodeling of the gland into a milk-secretory organ. Pubertal and post-puber- tal development of the breast in females aids in preparing it to assume a func- tional state during pregnancy and lactation. Remarkably, this organ has the capacity to regress to a resting state upon cessation of lactation, and then undergo the same cycle of expansion and regression again in subsequent pregnancies during reproductive life. This plasticity suggests tight hormonal regulation, which is paramount for the normal function of the gland. This review presents the current status of knowledge of the normal macro- and micro-anatomy of the human mammary gland and the distinct changes it undergoes during the key developmental stages that characterize it, from em- bryonic life through to post-menopausal age. In addition, it discusses recent advances in our understanding of the normal function of the breast during lac- tation, with special reference to breastmilk, its composition, and how it can be utilized as a tool to advance knowledge on normal and aberrant breast devel- opment and function.
    [Show full text]
  • The Milk Supply Equation
    The Making of a Milk Factory Objectives . List the major factors necessary for good milk production . Describe the role of the placenta in mammary gland development during pregnancy. Explain two ways that environmental The Making of a Milk Factory contaminants may interfere with reproductive hormones © 2019 Lisa Marasco MA, IBCLC, FILCA Hormones and Receptors The Milk Supply Equation SUFFICIENT GLANDULAR TISSUE + INTACT NERVE PATHWAYS & DUCTS + ADEQUATE HORMONES & RECEPTORS + ADEQUATE LACTATION-CRITICAL NUTRIENTS + ADEQUATE & EFFECTIVE MILK REMOVAL (Good management, effective baby) = GOOD MILK SUPPLY Directors of the process Important players by stage Hormones important to milk production Puberty Pregnancy Lactation Insulin Estrogen Estrogen Cortisol Lactogenic Progesterone Progesterone Complex HPL Prolactin Chorionic Gonadotropin Maintains metabolism; Growth Hormone Growth Hormone Thyroxine - Supports & directs IGF-1 IGF-1 PTPRF pituitary Prolactin Prolactin Insulin Insulin Regulate mammary blood Cortisol Cortisol PTHrP - flow; calcium transport and Thyroxine Thyroxine homeostasis PTHrP PTHrP Oxytocin Oxytocin - milk delivery With permission: Andaluz Waterbirth Center © Lisa Marasco 2019 1 The Making of a Milk Factory Hormone receptors 101 Hormone Receptors 201 Hormones- travel thru blood or synthesized locally Dynamic: Expressed by genes ER α, β Expressed PR α, β R Up & down regulation where and PRLR L, S Can be resistant as needed OTR H Can be hypersensitive Can be influenced positively or negatively by other hormones Receptors: Integral to hormone function, located on “target tissues,” on or in cells Can be influenced by environment The Big Construction Picture PR-A Phase I ER PR-B ERα Series of stages of organo-genesis lasting until ERβ PRLrL adulthood that are irreversible (fetal through puberty) PR-B Phase II Series of changes involving growth and secretory differentiation of the lobulo-alveolar system that are reversible Estrogen Prolactin Progesterone (Preg, lactation, involution) Horseman, N.
    [Show full text]
  • The Tanner Stages
    Vermont Department of Health Health Screening Recommendations for Children & Adolescents The Tanner Stages Because the onset and progression of puberty are so variable, Tanner has proposed a scale, now uniformly accepted, to describe the onset and progression of pubertal changes (Fig. 9- I Preadolescent 24). Boys and girls are rated on a 5 point scale. Boys are rated for genital development and no sexual hair pubic hair growth, and girls are rated for breast development and pubic hair growth. Pubic hair growth in females is staged as follows (Fig 9-24, B): II Sparse, pigmented, long, straight, • Stage I (Preadolescent) - Vellos hair develops over the pubes in a manner not greater than that over mainly along labia the anterior wall. There is no sexual hair. and at base of penis • Stage II - Sparse, long, pigmented, downy hair, which is straight or only slightly curled, appears. These hairs are seen mainly along the labia. This stage is difficult to quantitate on black and white photographs, particularly when pictures are of fair-haired subjects. III • Stage III - Considerably darker, coarser, and curlier sexual hair appears. The hair has now spread Darker, coarser, curlier sparsely over the junction of the pubes. • Stage IV - The hair distribution is adult in type but decreased in total quantity. There is no spread to the medial surface of the thighs. • Stage V - Hair is adult in quantity and type and appears to have an inverse triangle of the classically IV Adult, but feminine type. There is spread to the medial surface of the thighs but not above the base of the decreased inverse triangle.
    [Show full text]
  • PUBERTY: MY CHANGING BODY Lesson 2
    PUBERTY: MY CHANGING DIFFERING ABILITIES BODY Lesson 2 LEARNER OUTCOME Identify, label and discuss human reproductive body parts. MATERIALS: 1. Public Parts Illustrations (unlabelled &labelled) 2. Private Parts Illustrations (unlabelled & labelled) 3. Whole Body Including Public and Private Parts Illustration 4. Body Outlines 5. Male Reproductive Parts (unlabelled & labelled) 6. Female Reproductive Parts (unlabelled & labelled) 7. Female & Male Puberty Progression Illustrations INTRODUCTION : I t is important for students to identify the physical changes that will happen during puberty and to learn how to take care of their growing bodies. This lesson will help students to become familiar with the appropriate terms for reproductive body parts, a skill that can help students stay safe. Teaching students when to talk about body parts in conversation is an important concept as students learn about public versus private behaviours. APPROACHES/STRATEGIES: A. GROUND RULES Ensure ground rules are established before beginning this lesson. For classes that have already established ground rules, quickly reviewing them can promote a successful lesson. DA.201708 © 2017 teachingsexualhealth.ca 1 You should be prepared for giggles in your class. Try to Having Ground acknowledge students’ reactions to the subject by Rules in place can be saying that puberty and body parts can be difficult to a very successful way talk about and it’s ok to feel a bit uncomfortable. to facilitate a positive classroom B. ESTABLISHING LANDMARKS – TALKING environment. Click ABOUT PRIVATE BODY PARTS here for more information on how to 1. Get your students to feel for their hipbones. set up ground rules. 2. Explain that we are going to be talking about our bodies, the changes our bodies go through as we grow up and the names for our private body parts.
    [Show full text]
  • Evidence for the Ten Steps to Successful Breastfeeding
    WHO/CHD/98.9 DISTR.: GENERAL ORIGINAL: ENGLISH Evidence for the Ten Steps to Successful Breastfeeding DIVISION OF CHILD HEALTH AND DEVELOPMENT World Health Organization Geneva 1998 © World Health Organization 1998 This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced or translated, in part or in whole, but not for sale or for use in conjunction with commercial purposes. The designations employed and the presentation of the material in this document do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The views expressed in documents by named authors are solely the responsibility of those authors. Cover illustration adapted from a poster by permission of the Ministry of Health, Peru. Contents INTRODUCTION............................................................................................................................1 Methods used in the review Presentation of information The Ten Steps to Successful Breastfeeding 1. Step 1: Policies..................................................................................................................... 6 1.1 Criteria ........................................................................................................
    [Show full text]
  • Human Development: from Conception to Maturity Desenvolvimento Humano: Da Concepção À Maturidade
    Review Campinas, v. 20, e2016161, 2017 http://dx.doi.org/10.1590/1981-6723.16116 ISSN 1981-6723 on-line version Human development: from conception to maturity Desenvolvimento humano: da concepção à maturidade Valdemiro Carlos Sgarbieri1, Maria Teresa Bertoldo Pacheco2* 1 Universidade Estadual de Campinas (UNICAMP), Faculdade de Engenharia de Alimentos, Departamento de Alimentos e Nutrição, Campinas/SP - Brazil 2 Secretaria de Agricultura e Abastecimento do Estado de São Paulo (SAA), Agência Paulista de Tecnologia dos Agronegócios (APTA), Instituto de Tecnologia de Alimentos (ITAL), Centro de Ciência e Qualidade de Alimentos, Campinas/SP - Brazil *Corresponding Author Maria Teresa Bertoldo Pacheco, Secretaria de Agricultura e Abastecimento do Estado de São Paulo (SAA), Agência Paulista de Tecnologia dos Agronegócios (APTA), Instituto de Tecnologia de Alimentos (ITAL), Centro de Ciência e Qualidade de Alimentos, Avenida Brasil, 2880, Caixa Postal: 139, CEP: 13070-178, Campinas/SP - Brazil, e-mail: [email protected] Cite as: Human development: from conception to maturity. Braz. J. Food Technol., v. 20, e2016161, 2017. Received: Nov. 07, 2016; Approved: Jan. 13, 2017 Abstract The main objective of this review was to describe and emphasize the care that a woman must have in the period prior to pregnancy, as well as throughout pregnancy and after the birth of the baby, cares and duties that should continue to be followed by mother and child throughout the first years of the child’s life. Such cares are of nutritional, behavioral and lifestyle natures, and also involve the father and the whole family. Human development, from conception to maturity, consists of a critical and important period due to the multitude of intrinsic genetic and environmental factors that influence, positively or negatively, the person’s entire life.
    [Show full text]
  • Delayed Menarche: What Does It Look Like? What to Do?
    Delayed menarche: what does it look like? what to do? Melina Dendrinos, MD Michigan Medicine Primary Care for Women Conference 12/5/19 Disclosures • No significant financial interests or other relationships with industry relative to topics that will be discussed. Objectives • After this lecture the learner will be able to 1. Review normal pubertal development 2. Recognize delayed menarche and create a differential diagnosis. 3. Describe a plan for initial evaluation of delayed menarche. Puberty • Complex sequence of biological events resulting in • Maturation of secondary sex characteristics • Breast development (thelarche) • Pubic and axillary hair development (adrenarche) • Accelerated linear growth • Attainment of reproductive capacity Emans and Laufer, 2012 Onset of puberty • Mechanism of initiation of puberty is poorly understood • Inhibitory, stimulatory, and nutrition-dependent factors act on hypothalamus • Gradual changes in amplitude and frequency of GnRH pulses from the hypothalamus. • Timing of initiation is dependent on • Genetics • Health and nutrition Emans and Laufer, 2012 Changes in GnRH pulsatility • Prepubertal • Early pubertal • Late pubertal Oxford Textbook of Endocrinology and Diabetes, 2011 Hypothalamic-pituitary-ovarian axis • GnRH causes secretion of gonadotropins • Ovarian stimulation • Maturation of germinal epithelium • Synthesis of hormones • LH acts on theca cells • Produce androgen precursors • FSH acts on granulosa cells • Produce aromatase to convert precursors to estradiol Emans and Laufer, 2012 Effects
    [Show full text]
  • VIEW Open Access Environmental Exposures During Windows of Susceptibility for Breast Cancer: a Framework for Prevention Research Mary Beth Terry1†, Karin B
    Terry et al. Breast Cancer Research (2019) 21:96 https://doi.org/10.1186/s13058-019-1168-2 REVIEW Open Access Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research Mary Beth Terry1†, Karin B. Michels2†, Julia Green Brody3, Celia Byrne4, Shiuan Chen5, D. Joseph Jerry6, Kristen M. C. Malecki7, Mary Beth Martin8, Rachel L. Miller9, Susan L. Neuhausen10, Kami Silk11, Amy Trentham-Dietz12* and on behalf of Breast Cancer and the Environment Research Program (BCERP) Abstract Background: The long time from exposure to potentially harmful chemicals until breast cancer occurrence poses challenges for designing etiologic studies and for implementing successful prevention programs. Growing evidence from animal and human studies indicates that distinct time periods of heightened susceptibility to endocrine disruptors exist throughout the life course. The influence of environmental chemicals on breast cancer risk may be greater during several windows of susceptibility (WOS) in a woman’s life, including prenatal development, puberty, pregnancy, and the menopausal transition. These time windows are considered as specific periods of susceptibility for breast cancer because significant structural and functional changes occur in the mammary gland, as well as alterations in the mammary micro-environment and hormone signaling that may influence risk. Breast cancer research focused on these breast cancer WOS will accelerate understanding of disease etiology and prevention. Main text: Despite the plausible heightened mechanistic influences of environmental chemicals on breast cancer risk during time periods of change in the mammary gland’s structure and function, most human studies of environmental chemicals are not focused on specific WOS.
    [Show full text]
  • Introduction Epidemiology
    Review Article Endocrinology Medical Journal of Islamic World Academy of Sciences doi: 10.5505/ias.2017.03708 2017;25(2): 25-30 Evaluation of Patients with Hyperprolactinemia Muzaffer İLHAN1, Seda TURGUT2 1 Department of Endocrinology and Metabolism, Bezmialem Vakıf University, İstanbul, Turkey. 2 Department of Internal Medicine, Bezmialem Vakıf University, İstanbul, Turkey. ABSTRACT Hyperprolactinemia is characterized by the elevation of prolactin levels in circulation. It is the most common disorder of the hypothalamic–pituitary axis. Proper evaluation of the etiology in these patients is extremely important for the accurate follow-up and treatment. This review study aimed to discuss differential diagnoses and key points in patients with hyperprolactinemia. Key words: Hyperprolactinemia, macroprolactinemia, prolactinoma INTRODUCTION Prolactin (PRL) is one of the anterior pituitary hormones that plays an important role in reproductive functions. Besides its role in milk production during lactation, it also affects gonadal function by suppressing the action of luteinizing and follicle- stimulating hormones. Hyperprolactinemia is characterized by increased PRL levels in the blood. It is the most common endocrine disorder of the hypothalamo–hypophyseal–adrenal axis (1). Prolactinoma is the most common cause of hyperprolactinemia after excluding pregnancy primary hypothyroidism and the use of drugs, which can also lead to hyperprolactinemia (2). Menstrual disturbances, infertility, and galactorrhea in women, sexual dysfunction and infertility in men, as well as functional evaluation of pituitary tumors are frequent areas of PRL measurement in the clinic. While investigating the etiology of hyperprolactinemia, clinicians should be aware that some situations may lead to false diagnosis. This review study focused on the differential diagnosis of hyperprolactinemia and the signs leading to the correct diagnosis.
    [Show full text]
  • Implications of Breastfeeding in Triple Negative Breast Cancer THESIS
    Implications of Breastfeeding in Triple Negative Breast Cancer THESIS Presented in Partial Fulfillment of the Requirements for the Degree Master of Science in the Graduate School of The Ohio State University By Mustafa M. Basree Graduate Program in Anatomy The Ohio State University 2017 Thesis Committee: Bhuvaneswari Ramaswamy, MD MRCP, Research Advisor Gustavo Leone, PhD, Research Advisor Eileen Kalmar, PhD, Academic Advisor Sarmila Majumder, PhD Kirk McHugh, PhD Copyright by Mustafa M. Basree 2017 Abstract Due to high mortality associated with triple negative breast cancer (TNBC), a prevention program has the potential to protect many women against this disease. Recent epidemiological and meta-analysis studies revealed a possible correlation between a lack of breastfeeding and development of TNBC. African-American (AA) women have a disproportionate burden of developing aggressive TNBC, a sub-population with higher parity rates and lower prevalence of breastfeeding. The reasons for why parity and breastfeeding affect breast cancer risk are unclear, but recent studies revealed that the pregnancy-lactation cycle (which leads to remodeling of the mammary glands) alters breast morphology and microenvironment, thereby modifying breast cancer risk. Natural weaning (NW), the gradual cessation of breastfeeding, results in a measured reduction of the ductal structures, termed involution. Conversely, the decision not to breastfeed results in a hastened involution, or abrupt involution (AW). We modeled NW and AW in wild- type mice by restricting breastfeeding to 28 and 7 days respectively. Striking differences in the distribution of cell populations were observed in the mammary glands of AW mice compared to NW mice. Fluorescence activated cell sorting analysis revealed an expansion of the luminal progenitor cells with a concomitant decrease in mammary stem- cell enriched/basal compartment in the glands of the AW cohort.
    [Show full text]
  • Think Pink, Live Green: Protect Your Breast Health for Women and Girls
    Think Pink, Live Green: Protect Your Breast Health for Women and Girls Keynote Speaker: Dr. Marisa Weiss, Founder and President, Breastcancer.org Dr. Weiss’s presentation shared early research results of a study done in collaboration with Harvard Medical School and breastcancer.org. The researchers were interested in finding out why is the breast the favorite place for cancer to occur in women and what opportunities women have to reduce the risk of getting breast cancer or having breast cancer recur. Dr. Weiss noted that tremendous advances have been made in breast cancer over the years, including improved diagnostics with digital mammography, better ways to image the breast using MRI scans, new surgical techniques, and better targeted therapies that produce better benefits and reduce the side effects of more broad treatments like radiation or chemotherapy. We also have a better understanding of the genetic factors that may influence breast cancer risk and more extensive support networks, such as breastcancer.org. Despite these advances, however, breast cancer has become the most common cancer to affect women and the incidence of breast cancer is likely to double by 2040. Right now there are 1.3 million cases per year around the world; that will double and it will increasingly be seen in younger women. The highest increase in the incidence rates will be seen in big, developing countries like China and India. In the United States we expect a 19% increase in the next 20 years. Dr Weiss summarized the factors that are playing a role in these increasingly high numbers as the unique structure and development of the breast as an organ, our modern life style, reproductive choices and environmental factors.
    [Show full text]